MARLBOROUGH, Mass., Feb. 21, 2025 /PRNewswire/ — Boston Scientific Corporation (the “Company”) (NYSE: BSX) today announced that American Medical Systems Europe B.V. (“AMS Europe”), its wholly owned finance subsidiary, has priced a public offering of €850,000,000 […]
The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company” or “Co-Dx”), a […]
This esteemed event serves as a pivotal training experience for oncology Fellows and Residents, equipping them with essential knowledge, professional insights, and career navigation tools as they transition into the oncology workforce. The program will […]
ABBOTT PARK, Ill., Feb. 21, 2025 /PRNewswire/ — The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share. This marks the 405th consecutive quarterly dividend to […]
SILVER SPRING, Md., Feb. 21, 2025 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, […]
